Gossamer Bio, Inc.

DB:4GB Stock Report

Market Cap: €182.4m

Gossamer Bio Management

Management criteria checks 3/4

Gossamer Bio's CEO is Faheem Hasnain, appointed in Nov 2020, has a tenure of 4.08 years. total yearly compensation is $2.10M, comprised of 29% salary and 71% bonuses, including company stock and options. directly owns 2.44% of the company’s shares, worth €4.45M. The average tenure of the management team and the board of directors is 3.8 years and 3.5 years respectively.

Key information

Faheem Hasnain

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage29.0%
CEO tenure4.1yrs
CEO ownership2.4%
Management average tenure3.8yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Faheem Hasnain's remuneration changed compared to Gossamer Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$72m

Jun 30 2024n/an/a

-US$81m

Mar 31 2024n/an/a

-US$173m

Dec 31 2023US$2mUS$607k

-US$180m

Sep 30 2023n/an/a

-US$187m

Jun 30 2023n/an/a

-US$207m

Mar 31 2023n/an/a

-US$221m

Dec 31 2022US$7mUS$592k

-US$229m

Sep 30 2022n/an/a

-US$230m

Jun 30 2022n/an/a

-US$231m

Mar 31 2022n/an/a

-US$234m

Dec 31 2021US$5mUS$574k

-US$234m

Sep 30 2021n/an/a

-US$242m

Jun 30 2021n/an/a

-US$240m

Mar 31 2021n/an/a

-US$247m

Dec 31 2020US$1mUS$72k

-US$243m

Sep 30 2020n/an/a

-US$233m

Jun 30 2020n/an/a

-US$224m

Mar 31 2020n/an/a

-US$202m

Dec 31 2019US$1mUS$200k

-US$180m

Sep 30 2019n/an/a

-US$164m

Jun 30 2019n/an/a

-US$165m

Mar 31 2019n/an/a

-US$154m

Dec 31 2018US$19mUS$470k

-US$147m

Compensation vs Market: Faheem's total compensation ($USD2.10M) is above average for companies of similar size in the German market ($USD902.55K).

Compensation vs Earnings: Faheem's compensation has been consistent with company performance over the past year.

CEO

Faheem Hasnain (66 yo)

4.1yrs

Tenure

US$2,095,988

Compensation

Mr. Faheem Hasnain has been Chief Executive Officer and President at Gossamer Bio, Inc. since November 16, 2020. He served as Executive Advisor at Vertex Ventures HC since joining the firm on October 29, 2...

Leadership Team

NamePositionTenureCompensationOwnership
Faheem Hasnain
Co-Founder4.1yrsUS$2.10m2.44%
€ 4.5m
Bryan Giraudo
COO & CFO6.6yrsUS$1.29m0.25%
€ 461.1k
Robert Smith
Chief Commercial Officerless than a yearUS$1.33mno data
Christian Waage
Executive Vice President of Technical Operations & Administration2.8yrsUS$1.65m0.29%
€ 526.5k
Jeff Boerneke
General Counsel & Secretary3.9yrsno datano data
Deanna Weber
Senior Vice President of Human Resourcesno datano datano data
Richard Aranda
Chief Medical Officerno dataUS$2.48m0.088%
€ 160.6k
Caryn Peterson
Executive Vice President of Regulatory Affairsno datano data0.022%
€ 40.1k
Matt Cravets
Senior Vice President of Biometrics3.8yrsno datano data
Lisa Nolan
MD & President of Gossamer Bio Ireland2.9yrsno datano data

3.8yrs

Average Tenure

62yo

Average Age

Experienced Management: 4GB's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Faheem Hasnain
Co-Founder9.2yrsUS$2.10m2.44%
€ 4.5m
Russell Cox
Independent Director6.1yrsUS$87.32k0.0032%
€ 5.8k
Thomas Daniel
Lead Independent Director6.9yrsUS$98.82k0.017%
€ 30.7k
John Quisel
Independent Director1.1yrsUS$133.61k0%
€ 0
Sandra Milligan
Independent Director3.5yrsUS$81.82k0.014%
€ 25.8k
Steven Nathan
Independent Directorless than a yearno data0%
€ 0
Skye Drynan
Independent Directorless than a yearno data0%
€ 0

3.5yrs

Average Tenure

61yo

Average Age

Experienced Board: 4GB's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gossamer Bio, Inc. is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carter GouldBarclays
Zhilin LongBerenberg
Patrick TrucchioBerenberg